Carman Alenson
Comptroller/Controller/Auditor chez PRIME MEDICINE, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Carman Alenson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01/08/2021 | - |
| Directeur Financier/CFO | 01/08/2021 | 17/01/2024 |
Historique de carrière de Carman Alenson
Anciens postes connus de Carman Alenson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 07/11/2016 | 30/07/2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2015 | 01/10/2016 |
Formation de Carman Alenson
| Boston University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Israël | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Carman Alenson
- Expérience
